Evidence method
Level · gp.fundamentals.capex_revenue_ratio
33.25% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRBU · Sep 30, 2024
Caribou Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001619856-24-000081General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1613.69% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-91.45% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-1889.23% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1503.01% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
201.04% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 64.69%
- Current
- 33.25%
- Delta
- -31.44%
- Previous
- -948.79%
- Current
- -1613.69%
- Delta
- -664.90%
- Previous
- -7.75%
- Current
- -91.45%
- Delta
- -83.70%
- Previous
- -1255.80%
- Current
- -1889.23%
- Delta
- -633.43%
- Previous
- 1024.25%
- Current
- 1503.01%
- Delta
- 478.76%
- Previous
- 136.78%
- Current
- 201.04%
- Delta
- 64.26%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CRBU Fundamental State →Has State · Caribou Biosciences, Inc. →Transitioned To · CRBU Fundamental State →Transitioned To · CRBU CAPEX_INTENSITY_DECREASED →Transitioned To · CRBU CASH_GENERATION_DECREASED →Transitioned To · CRBU GROWTH_DECREASED →Transitioned To · CRBU PROFITABILITY_DECREASED →Transitioned To · CRBU R_AND_D_INTENSITY_INCREASED →Transitioned To · CRBU SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.